Martin H Johnson1, Kerry Petersen. 1. Department of Physiology, Development and Neuroscience, University of Cambridge, UK. mhj21@cam.ac.uk
Abstract
BACKGROUND: Assisted reproductive technologies (ART) bear a heavy regulatory burden in some jurisdictions. This burden constrains patient autonomy and the professional autonomy of doctors and scientists. METHODS: We question why this should be by analyzing the possible public interests in ART regulation under the headings: health, financial, ethico-legal and socio-political. Throughout, we try to identify whether comparable public interest claims are made for other areas of medicine, but accommodated without the requirement for specialized statutory frameworks such as those exemplified in the UK and Victoria (Australia). RESULTS: We identify a small core of public interest concerns that seem to justify some sort of special regulatory structure, but not one as elaborate as those currently in place. We then develop a five-step quality control model, familiar to biomedical practice but novel in the context of legal thinking, to aid development and review of regulatory policy and practice. This model is applied both prospectively to the proposal to record 'by donation' on birth certificates, and retrospectively to the regulation of parental choice about the genetic make-up of offspring in UK and Victorian jurisdictions. CONCLUSIONS: The model provides a useful and robust framework for pin-pointing problems with regulatory regimes, to stimulate empirical research, and to facilitate both the review and development of regulatory policy.
BACKGROUND: Assisted reproductive technologies (ART) bear a heavy regulatory burden in some jurisdictions. This burden constrains patient autonomy and the professional autonomy of doctors and scientists. METHODS: We question why this should be by analyzing the possible public interests in ART regulation under the headings: health, financial, ethico-legal and socio-political. Throughout, we try to identify whether comparable public interest claims are made for other areas of medicine, but accommodated without the requirement for specialized statutory frameworks such as those exemplified in the UK and Victoria (Australia). RESULTS: We identify a small core of public interest concerns that seem to justify some sort of special regulatory structure, but not one as elaborate as those currently in place. We then develop a five-step quality control model, familiar to biomedical practice but novel in the context of legal thinking, to aid development and review of regulatory policy and practice. This model is applied both prospectively to the proposal to record 'by donation' on birth certificates, and retrospectively to the regulation of parental choice about the genetic make-up of offspring in UK and Victorian jurisdictions. CONCLUSIONS: The model provides a useful and robust framework for pin-pointing problems with regulatory regimes, to stimulate empirical research, and to facilitate both the review and development of regulatory policy.